Difference between revisions of "Zhang S, et al. Cancer Biol. Ther. (2014) cited as Ref 582 in DOI: 10.1038/s41392-020-0110-5 (Q9845)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 15, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Targeting Met and Notch in the Lfng-deficient Met-amplified triple-negative breast cancer, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Targeting Met and Notch in the Lfng-deficient Met-amplified triple-negative breast cancer (English) | ||
| Property / title: Targeting Met and Notch in the Lfng-deficient Met-amplified triple-negative breast cancer (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:04, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zhang S, et al. Cancer Biol. Ther. (2014) cited as Ref 582 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zhang S
0 references
Chung WC
0 references
Miele L
0 references
2014
0 references
Cancer Biol. Ther.
0 references
15
0 references
Targeting Met and Notch in the Lfng-deficient Met-amplified triple-negative breast cancer (English)
0 references
